197 related articles for article (PubMed ID: 22990556)
21. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix.
Zhao S; Hayasaka T; Osakabe M; Kato N; Nakahara K; Kurachi H; Fukase M; Katayama Y; Yaegashi N; Motoyama T
Int J Gynecol Pathol; 2003 Oct; 22(4):393-7. PubMed ID: 14501822
[TBL] [Abstract][Full Text] [Related]
22. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions.
Michael H; Grawe L; Kraus FT
Int J Gynecol Pathol; 1984; 3(3):261-76. PubMed ID: 6500801
[TBL] [Abstract][Full Text] [Related]
23. Cytologic features of villoglandular adenocarcinoma of the uterine cervix: comparison with typical endocervical adenocarcinoma with a villoglandular component and papillary serous carcinoma.
Chang WC; Matisic JP; Zhou C; Thomson T; Clement PB; Hayes MM
Cancer; 1999 Feb; 87(1):5-11. PubMed ID: 10096353
[TBL] [Abstract][Full Text] [Related]
24. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
[TBL] [Abstract][Full Text] [Related]
25. Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature.
Stanley-Christian H; Heim BK; Hines JF; Hall KL; Willett GD; Barnes WA
Gynecol Oncol; 1997 Aug; 66(2):327-30. PubMed ID: 9264585
[TBL] [Abstract][Full Text] [Related]
26. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: assessment of cytological features by histological subtypes.
Hagiwara T; Kaku T; Kobayashi H; Wake N; Saito T
Acta Cytol; 2013; 57(1):61-8. PubMed ID: 23221334
[TBL] [Abstract][Full Text] [Related]
27. Colloid carcinoma of the intestinal type in the uterine cervix: mucin immunohistochemistry.
Shintaku M; Kushima R; Abiko K
Pathol Int; 2010 Feb; 60(2):119-24. PubMed ID: 20398197
[TBL] [Abstract][Full Text] [Related]
28. Mixed papillary transitional cell carcinoma and adenocarcinoma of the uterine cervix: a clinicopathologic study of three cases.
Robinson CE; Sarode VR; Albores-Saavedra J
Int J Gynecol Pathol; 2003 Jul; 22(3):220-5. PubMed ID: 12819386
[TBL] [Abstract][Full Text] [Related]
29. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
30. [A clinical study on endocervical type and endometrioid type cervical adenocarcinoma].
Yoshida K; Okuda H; Hayashi Y; Kondo T; Sekiba K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1329-32. PubMed ID: 1955785
[TBL] [Abstract][Full Text] [Related]
31. Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas.
Tian X; Shigemasa K; Hirata E; Gu L; Uebaba Y; Nagai N; O'Brien TJ; Ohama K
Oncol Rep; 2004 Nov; 12(5):1001-6. PubMed ID: 15492784
[TBL] [Abstract][Full Text] [Related]
32. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
[TBL] [Abstract][Full Text] [Related]
33. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
34. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
[TBL] [Abstract][Full Text] [Related]
35. [Microglandular endocervical hyperplasia and endocervical adenocacinoma in pregnant--description of two cases].
Nikolova M; Marinov E; Stoĭkov S; Gorchev G; Tomov S
Akush Ginekol (Sofiia); 2005; 44(2):41-3. PubMed ID: 15853028
[TBL] [Abstract][Full Text] [Related]
36. [Morphology, immunohistochemistry and differential diagnosis of 70 cases of adenocarcinoma of uterine cervix].
Huang J
Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):98-100. PubMed ID: 8403106
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion.
Ueki M; Ueda M; Okamura S; Yamada T
J Med; 1995; 26(1-2):17-30. PubMed ID: 7561528
[TBL] [Abstract][Full Text] [Related]
38. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
39. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
[TBL] [Abstract][Full Text] [Related]
40. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
